This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: Innovations in Cancer Treatment by So-Young Jeong
Introduction
So-Young Jeong is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of cancer research, particularly in the development of pharmaceutical compositions aimed at enhancing TRAIL sensitivity in cancer cells. With a total of 2 patents, her work is paving the way for new therapeutic strategies in oncology.
Latest Patents
One of her latest patents focuses on a composition for enhancing TRAIL sensitivity, which includes inhibitors for the expression or activity of TIP41. This invention is particularly relevant for the prevention and treatment of various cancers, including liver, lung, and colon cancers. The research demonstrates that when liver cancer cell lines resistant to TRAIL are treated with TIP41 siRNA and TRAIL, apoptosis is induced in the cancer cells. This effect has also been confirmed in tumor xenograft models, where a reduction in tumor size was observed following treatment. The MKK7/JNK signaling pathway was identified as a mediator of the apoptosis induced by this combination treatment.
Another significant patent involves the gastric carcinoma gene ZNF312b. This invention relates to a diagnostic marker for stomach cancer, as the expression of the ZNF312b gene is specifically increased in stomach cancer cases. The over-expression or under-expression of this gene affects cell proliferation and tumor formation, making it a valuable tool for diagnosis and the development of specific anticancer agents.
Career Highlights
So-Young Jeong is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where she conducts her research. Her innovative work has garnered attention in the scientific community, contributing to advancements in cancer treatment methodologies.
Collaborations
She collaborates with notable colleagues, including Cheol-Hee Kim and Hyun-Taek Kim, who share her commitment to advancing cancer research.
Conclusion
So-Young Jeong's contributions to cancer research through her innovative patents highlight the potential for new therapeutic approaches in oncology. Her work not only enhances our understanding of cancer mechanisms but also offers hope for improved treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile